TFS Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-14,012
Closed -$581K 289
2017
Q2
$581K Buy
+14,012
New +$532K 0.23% 150
2016
Q3
Sell
-33,446
Closed -$915K 937
2016
Q2
$915K Sell
33,446
-35,722
-52% -$913K 0.17% 197
2016
Q1
$1.85M Buy
69,168
+42,582
+160% +$1.04M 0.27% 87
2015
Q4
$752K Sell
26,586
-35,216
-57% -$1.02M 0.08% 341
2015
Q3
$1.72M Buy
+61,802
New +$2.23M 0.17% 194
2015
Q1
Sell
-56,678
Closed -$1.12M 1104
2014
Q4
$1.12M Buy
+56,678
New +$1.27M 0.11% 297
2014
Q3
Sell
-205,353
Closed -$4.68M 1180
2014
Q2
$4.68M Buy
+205,353
New +$3.66M 0.37% 33
2014
Q1
Sell
-22,273
Closed -$304K 1542
2013
Q4
$304K Sell
22,273
-12,856
-37% -$153K 0.01% 1092
2013
Q3
$390K Buy
35,129
+4,014
+13% +$39.9K 0.02% 990
2013
Q2
$256K Buy
+31,115
New +$261K 0.01% 1217

Other funds holding RGEN

TFS Capital's RGEN Position: Q3 2017 in Review

TFS Capital sold out of Repligen (RGEN) in Q3 2017, closing a stake of 14,012 shares — an estimated $581K sold.

TFS Capital first reported a position in RGEN in Q2 2013 and held it in 10 quarters. The position peaked at $4.68M in Q2 2014. 190 funds tracked by Wall St. Rank hold RGEN as of Q3 2017.

  • TFS Capital reported no remaining Repligen position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 14,012 Repligen shares in Q3 2017, an estimated $581K.
  • TFS Capital first reported a position in Repligen in Q2 2013 and held it in 10 quarters.
  • TFS Capital's Repligen position peaked at $4.68M in Q2 2014.
  • 190 funds tracked by Wall St. Rank held Repligen as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.